Aaron Kimball serves as Executive at Zymergen Inc., where they oversee executive responsibilities. Since joining the company, Aaron Kimball has executed 8 insider transactions totaling $574.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 1, 2022 involved selling 7,639 shares valued at $22.5K.
Aaron Kimball currently holds 712,644 shares of Zymergen Inc. (ZY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aaron Kimball has been a net seller of ZY stock. They have purchased $0 and sold $574.2K worth of shares.
Aaron Kimball's most recent insider trade was on Apr 1, 2022, when they sold 7,639 shares at $2.94 per share.
Get notified when new Form 4 filings are submitted
| $2.84 |
| Discretionary |
| Mar 1, 2022 | ZY | $95.3K | Sale | 25,000 | $3.81 | Discretionary |
| Feb 1, 2022 | ZY | $126.5K | Sale | 25,000 | $5.06 | Discretionary |
| Jan 18, 2022 | ZY | $259.0K | Sale | 50,000 | $5.18 | Discretionary |
| Nov 22, 2021 | ZY | $0 | Gift | 5,000 | $N/A | Discretionary |
| Oct 26, 2021 | ZY | $0 | Award | 85,000 | $N/A | Discretionary |
| Oct 6, 2021 | ZY | $40.2K | Option Exercise | 9,000 | $4.47 | Discretionary |